Position in QGEN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,117,638
New position
Shares Held
79,735
first reported quarter
Ownership
0.039%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#115
of 332 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Lansforsakringar Fondforvaltning AB (publ) holds $191,892,065 across 12 Diagnostics & Research names. QGEN ranks #12 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
131,916 | $66,137,405 | |
| 2 | DHR |
Danaher Corp /De/
|
196,388 | $37,407,986 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
24,161 | $12,719,316 | |
| 4 | A |
Agilent Technologies, Inc.
|
88,456 | $11,749,610 | |
| 5 | WAT |
Waters Corp /De/
|
30,952 | $11,608,238 | |
| 6 | NTRA |
Natera, Inc.
|
40,580 | $11,015,441 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
51,226 | $9,897,887 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
6,414 | $8,193,949 |
All Filings in QGEN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,117,638 | 79,735 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||